Eksponering for nilotinib hos hunner ved NOAEL var generelt mindre end eller lig med eksponeringen hos mennesker ved 800 mg/ dag.
Exposure to nilotinib in females at No-Observed- Adverse-Effect-Levels was generally less or equal to that in humans at 800 mg/ day.